Pharmacodynamic biomarker analysis of gastrointestinal cancer patients treated with metronomic chemotherapy in the Italian COMET Trial

被引:0
|
作者
Manca, Maria L.
Prospero, Diana
Darvishi, Saeedeh
Bandini, Arianna
Banchi, Marta
Orlandi, Paola
Padilla, Hector
Sanchez, Alejandro
Perucho, Claire E.
de Avila, Nydia
Padilla, Hazel
Ortega, Brianna E.
Stewart, Ryley D.
Santillan, Magdiel
Lopez, Valeria
Kirken, Robert
Allegrini, Giacomo
Bocci, Guido
Francia, Giulio
机构
关键词
D O I
10.1158/1538-7445.AM2024-5180
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5180
引用
收藏
页数:2
相关论文
共 50 条
  • [31] The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer
    Ming-Yu Hsieh
    Gene Chen
    Dun-Cheng Chang
    Su-Yu Chien
    Mu-Kuan Chen
    Annals of Surgical Oncology, 2018, 25 : 2091 - 2097
  • [32] Molecular biomarker analysis and survival in patients (pts) with advanced urothelial cancer (UC) previously treated with chemotherapy.
    Szabados, Bernadett
    Rebelatto, Marlon
    Barker, Craig
    Milner, Alvin
    Lewis, Arthur
    Stokes, Michael
    Zajac, Magda
    Powles, Thomas
    Shire, Norah J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer
    Patil, V. M.
    Noronha, V
    Joshi, A.
    Nayak, L.
    Pande, N.
    Chandrashekharan, A.
    Dhumal, S.
    Bhattacharjee, A.
    Banavali, S.
    Prabhash, K.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 25 - +
  • [34] Pharmacokinetic and pharmacodynamic analysis of combined chemotherapy with carboplatin and paclitaxel for patients with ovarian cancer
    Arakawa A.
    Nishikawa H.
    Suzumori K.
    Kato N.
    International Journal of Clinical Oncology, 2001, 6 (5) : 248 - 252
  • [35] The comprehensive analysis of UGT1A genetic polymorphisms in patients with metastatic gastrointestinal cancer treated with irinotecan chemotherapy
    Tsujinaka, T.
    Satoh, T.
    Ura, T.
    Sasaki, Y.
    Yamazaki, K.
    Munakata, M.
    Yamada, Y.
    Ishizuka, N.
    Hyodo, I.
    Sakata, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 144 - 144
  • [36] Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
    Jung, Yun Hwa
    Lee, Won Jik
    Byeon, Jae Ho
    Lee, In Kyu
    Han, Chi Wha
    Woo, In Sook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 926 - 929
  • [37] Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer
    Orlando, Laura
    Cardillo, Anna
    Rocca, Andrea
    Balduzzi, Alessandra
    Ghisini, Raffaella
    Peruzzotti, Giulia
    Goldhirsch, Aron
    D'Alessandro, Claudia
    Cinieri, Saverio
    Preda, Lorenzo
    Colleoni, Marco
    ANTI-CANCER DRUGS, 2006, 17 (08) : 961 - 967
  • [38] Gastrointestinal bleeding events in cancer patients treated with chemotherapy and anti-emetic drugs
    Frost, Alexandra C.
    Beiderbeck, Annette B.
    Wishart, Maria O.
    Tyczynski, Jerzy E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S164 - S165
  • [39] Serum protein profiling reveals baseline and pharmacodynamic biomarker signatures associated with clinical outcome in mCRC patients treated with chemotherapy ± cediranib
    Pommier, A. J. C.
    Shaw, R.
    Spencer, S. K. M.
    Morgan, S. R.
    Hoff, P. M.
    Robertson, J. D.
    Barry, S. T.
    Juergensmeier, J. M.
    BRITISH JOURNAL OF CANCER, 2014, 111 (08) : 1590 - 1604
  • [40] Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
    Giacomo Allegrini
    Teresa Di Desidero
    Maria Teresa Barletta
    Anna Fioravanti
    Paola Orlandi
    Bastianina Canu
    Silvio Chericoni
    Fotios Loupakis
    Antonello Di Paolo
    Gianluca Masi
    Andrea Fontana
    Sara Lucchesi
    Giada Arrighi
    Mario Giusiani
    Andrea Ciarlo
    Giovanni Brandi
    Romano Danesi
    Robert S. Kerbel
    Alfredo Falcone
    Guido Bocci
    Angiogenesis, 2012, 15 : 275 - 286